Zinger Key Points
- Medical marijuana company cbdMD is offering its products via the grocery chain, Sprouts Farmers Market.
- The company's two featured products, Apple Cider Vinegar (ACV) and Immunity Gummy Pouches will be available in 175 locations nationwide.
- China’s new tariffs just reignited the same market patterns that led to triple- and quadruple-digit wins for Matt Maley. Get the next trade alert free.
Medical cannabis company cbdMD, Inc. YCBD is now selling through the grocery chain, Sprouts Farmers Market with two featured products, Apple Cider Vinegar (ACV) and Immunity Gummy Pouches in 175 locations nationwide.
Sprouts Farmers Market has chosen cbdMD as a key brand for their CBD section, the Charlotte, North Carolina-based company said on Thursday.
Shannon Charles, CMO at cbdMD touted the move as "an honor that testifies to our unwavering commitment to quality and customer satisfaction,” adding that it "allows us to bring our premium gummies to more health-conscious consumers across the country."
The key features of cbdMD’s ACV and Immunity Gummies pouches include:
- The ACV Gummies promote digestive health by being infused with organic apple cider vinegar powder, providing 100% of daily Vitamin B12 and Folic Acid requirements.
- The Immunity Gummies are packed with essential vitamins C, D, E, Zinc, Selenium, and antioxidant-rich elderberry, supporting immune health.
- The gummies are vegan-friendly, gluten-free and in compliance with the Farm Bill.
“We’re excited about what this means for our future growth and expansion," Charles continued. "Our mission has always been to promote a balanced lifestyle and optimal wellness, and this partnership with Sprouts Farmers Market brings us one step closer to that goal."
YCBD Price Action
cbdMD, Inc.'s shares traded 0.8846% lower at $0.7843 per share at the time of writing on Friday.
Related News
- CBD Giant’s Challenging Year: Q4 Net Sales Slide By 27% But Net Loss Narrows 67% YoY
- cbdMD Reports Q3 2023 Performance: Net Loss Improves, Focus On Cost Management & Strategic Growth
- cbdMD Q2 2023 Results: Net Loss Improves, Costs Plummet
- cbdMD Secures $2.8M Via Underwritten Public Offering Of Common Stock
Edge Rankings
Price Trend
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving—don’t get left behind!
Curious about what’s next for the industry and how to stay ahead in today’s competitive market?
Join top executives, investors, and industry leaders at the Benzinga Cannabis Capital Conference in Chicago on June 9-10. Dive deep into market-shaping strategies, investment trends, and brand-building insights that will define the future of cannabis.
Secure your spot now before prices go up—this is where the biggest deals and connections happen!